Keyphrases
Soluble Suppression of Tumorigenicity 2 (sST2)
100%
Computational Design
100%
ScFv
100%
ST2L
36%
Interleukin-33 (IL-33)
27%
Tissue Repair
18%
Disease Severity
9%
Ulcerative Colitis
9%
Immune Regulation
9%
Cardiovascular Disease
9%
Therapeutic Use
9%
Flow Cytometry
9%
High Specificity
9%
High Selectivity
9%
Amino Acid Sequence
9%
Cross-reactivity
9%
Inflammatory Diseases
9%
Phage Display Library
9%
Fold Increase
9%
Asthma
9%
Transmembrane
9%
Binding Affinity
9%
Signaling Axis
9%
Key Binding
9%
Decoy Receptor
9%
Molecular Simulation
9%
Diagnostic Use
9%
Surface Plasmon Resonance Analysis
9%
Clinical Evidence
9%
Co-immunoprecipitation (co-IP)
9%
IL-1 Receptor
9%
Membrane Binding
9%
Enhanced Specificity
9%
Binding Residues
9%
Single-chain Variable Fragment
9%
C-terminus
9%
Biochemistry, Genetics and Molecular Biology
Interleukin 33
100%
Isoform
66%
Tissue Repair
66%
Interleukin-1
33%
Binding Affinity
33%
Peptide Sequence
33%
Cross Reaction
33%
Flow Cytometry
33%
Phage Display
33%
Surface Plasmon Resonance
33%
Immunoprecipitation
33%
Immunoregulation
33%
Single-Chain Variable Fragment
33%
C-Terminus
33%
Conformation
33%
Immunology and Microbiology
Interleukin 33
100%
Tissue Repair
66%
Cross-Reactivity
33%
Immunoregulation
33%
Ulcerative Colitis
33%
Interleukin 1
33%
Inflammatory Disorder
33%
Amino Acid Sequence
33%
Phage Display
33%
Binding Affinity
33%
Immunoprecipitation
33%
Single-Chain Variable Fragment
33%
Surface Plasmon Resonance
33%
Conformation
33%
Asthma
33%
Carboxy Terminal Sequence
33%
Neuroscience
Interleukin 33
100%
Receptor
66%
Amino Acid Sequence
33%
Single-Chain Variable Fragment
33%
Immunoprecipitation
33%
Binding Affinity
33%
Flow Cytometry
33%
C-Terminus
33%
Interleukin 1
33%